A clinical study to evaluate the efficacy of ceritinib in combination with nivolumab in patients with ALK positive lung cancer
CLDK378A2120C
Phase 1 other active
Quick answer
A clinical study to evaluate the efficacy of ceritinib in combination with nivolumab in patients with ALK positive lung cancer for Non-small cell lung cancer is a Phase 1 program (other) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Non-small cell lung cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active